TB District Surveillance Medical Officers are an integral part of NTP, Bangladesh

 

TB District Surveillance Medical Officers are an integral part of NTP until Bangladesh reaches the End  TB by 2030 - Dr. Zabeen

TB District Surveillance Medical Officers (DSMOs) is a part of the National Control Programme (NTP), in Bangladesh to END TB by 2030. Dr. Ahmed Parvez Zabeen, Divisional TB Expert, Dhaka South stresses the need for the DSMOs continuity in NTP until Bangladesh reaches Zero TB Deaths, Zero Tuberculosis, and Zero catastrophic cost. Dr. Zabeen further added that DSMOs hired by The Global Fund to Fight AIDS, Tuberculosis and Malaria  (GFATM) grant and requests government officials to include them in the currently developing operational plan of the Ministry of Health and Family Welfare (MoH&FP) to reach the Sustainable Development Goal (SDG) targets on TB at the DSMOs get together meeting. 

                              Dr. Ahmed Parvez Zabeen

Dr. Ibrahim Mazi, DSMO, Shariatpur informed the meeting about the DSMOs' different field-level activities. Dr. Joieta Tushi, DSMO, Naogoan, and others anchored the meeting. The DSMOs Welcomed the guests with flowers. The meeting ends with a video presentation of different field-level activities of all DSMOs.

Dr. Md Mahfuzur Rahman Sharkar, Line Director TB–Leprosy, and ASP presided over the meeting.

 

World TB DAY 2024

World TB DAY 2024

Civil Society Note

Point to Ponder

Dhaka begins the World TB Day 2024 celebration with the call YES! WE CAN END TB. The last year’s theme’s continuation YES! WE CAN END TB by 2023 to bring powers collectively to achieve the United Nations High-Level Meeting (UNHLM) on Tuberculosis 2023’s political targets to END TB; the theme narrates a few more things like the engagement of those affected by TB, communities, and civil society to lead the movement to END TB. 

The TB STUDY GROUP (TSG), a civil society organization in Bangladesh believes that diagnosis of Tuberculosis is difficult. The TSG stresses the expansion of molecular WHO Recommended Diagnostics Cartridge-based Nucleic Acid Amplification Test (CB-NAAT)- GeneXpert and Tuenut, innovation of newer drug for short-course treatment and use of Artificial Intelligence (AI) for ending this disease. 

 

The TSG also recommends early availability of anti-TB vaccine; the few anti-TB vaccine candidates in phase III trial. Those vaccines must complete the trials soon, the completion of safety tests, and those anti- TB vaccines must be available to save more lives from tuberculosis. 

 

The TSG firmly believes in the strength of those affected by Tuberculosis, communities, and civil societies that YES! WE CAN END TB; হ্যাঁ! আমরা যক্ষ্মা নির্মূল করতে পারি ।